Position in EDIT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$267,908
+$78,495 QoQ
Shares Held
108,465
+17.4% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. EDIT ranks #208 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in EDIT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $267,908 | 108,465 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $189,413 | 92,397 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $299,183 | 86,220 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $116,901 | 53,137 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $50,781 | 43,777 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $55,596 | 43,777 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $221,029 | 64,818 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $244,964 | 52,455 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $368,803 | 49,704 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $430,828 | 42,530 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $341,577 | 43,792 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $293,753 | 35,693 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $254,525 | 35,107 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $268,113 | 30,227 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $423,601 | 34,608 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $363,890 | 30,760 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $475,538 | 25,002 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $625,863 | 23,573 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,765,125 | 42,968 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,188,796 | 38,644 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,342,362 | 31,961 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,888,623 | 26,938 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $414,530 | 14,773 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||